NL175525C - Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat. - Google Patents

Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.

Info

Publication number
NL175525C
NL175525C NLAANVRAGE7900004,A NL7900004A NL175525C NL 175525 C NL175525 C NL 175525C NL 7900004 A NL7900004 A NL 7900004A NL 175525 C NL175525 C NL 175525C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
acylamino group
antibacterial action
derivative substituted
oleandomycin derivative
Prior art date
Application number
NLAANVRAGE7900004,A
Other languages
English (en)
Dutch (nl)
Other versions
NL175525B (nl
NL7900004A (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7900004A publication Critical patent/NL7900004A/xx
Publication of NL175525B publication Critical patent/NL175525B/xx
Application granted granted Critical
Publication of NL175525C publication Critical patent/NL175525C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NLAANVRAGE7900004,A 1978-01-03 1979-01-02 Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat. NL175525C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/866,891 US4133950A (en) 1978-01-03 1978-01-03 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters

Publications (3)

Publication Number Publication Date
NL7900004A NL7900004A (nl) 1979-07-05
NL175525B NL175525B (nl) 1984-06-18
NL175525C true NL175525C (nl) 1984-11-16

Family

ID=25348657

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7900004,A NL175525C (nl) 1978-01-03 1979-01-02 Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.

Country Status (11)

Country Link
US (1) US4133950A (fr)
JP (1) JPS5495586A (fr)
BE (1) BE873268A (fr)
DE (1) DE2900119C2 (fr)
DK (1) DK149629C (fr)
FR (1) FR2413405A1 (fr)
GB (1) GB2011891B (fr)
IE (1) IE47968B1 (fr)
IT (1) IT1109927B (fr)
LU (1) LU80745A1 (fr)
NL (1) NL175525C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316010A (en) * 1981-01-02 1982-02-16 Pfizer Inc. Cis-C3 "C4 "-carbonate derivatives of O-demethyloleandomycin and intermediates therefor
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin
US4125705A (en) * 1977-02-04 1978-11-14 Pfizer Inc. Semi-synthetic 4-amino-oleandomycin derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
SE446340B (sv) * 1977-05-11 1986-09-01 Pfizer Sett att framstella halvsyntetiska 4"-sulfonylamino-oleandomycinderivat
US4098993A (en) * 1977-07-25 1978-07-04 Pfizer Inc. Semi-synthetic 4-ureido-oleandomycin derivatives
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives

Also Published As

Publication number Publication date
FR2413405A1 (fr) 1979-07-27
NL175525B (nl) 1984-06-18
NL7900004A (nl) 1979-07-05
LU80745A1 (fr) 1979-09-07
FR2413405B1 (fr) 1981-04-17
JPS5495586A (en) 1979-07-28
IT7919015A0 (it) 1979-01-02
IE47968B1 (en) 1984-08-08
GB2011891A (en) 1979-07-18
DK149629C (da) 1987-02-02
GB2011891B (en) 1982-05-26
IE790002L (en) 1979-07-03
BE873268A (fr) 1979-07-02
IT1109927B (it) 1985-12-23
DK1479A (da) 1979-07-04
DE2900119C2 (de) 1983-10-27
DE2900119A1 (de) 1979-07-05
JPS5747198B2 (fr) 1982-10-07
DK149629B (da) 1986-08-18
US4133950A (en) 1979-01-09

Similar Documents

Publication Publication Date Title
NL176558C (nl) Gevormd preparaat met herbicide eigenschappen, alsmede daarvoor geschikt cyclohexaanderivaat.
NL7805510A (nl) Farmaceutisch preparaat met vertraagde afgifte.
NL175016B (nl) Veldhakselaar.
NL185622C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
NL191314C (nl) 3-Monogesubstitueerd-1-azetidine-carboxamidederivaat, alsmede een anticonvulsief preparaat.
NL7611944A (nl) 1,2,3-triazolen met kalmerende werking.
NL191777C (nl) Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.
NL192740B (nl) Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
NL176461C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd macrolide antibioticum.
NL7604914A (nl) 1,2,2,2-tetrafluorethyl-fluormethylether en zijn bereiding.
NL185923C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede penam-3-carbonzuur-1,1-dioxyde-derivaat.
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
NL190632B (nl) Oxadethiacefalosporinen en geneesmiddel met antibacteriele werking.
NL7801326A (nl) Pesticide-preparaten.
NL7801368A (nl) Pesticide-preparaten.
IT7925387A0 (it) 2-amminoetil-1-fenil-indoline, loro preparazione e loro applicazione come medicamenti.
NL7804361A (nl) Leucinerijk 3,1-s-alpha2-glycoproteine, zijn berei- ding en toepassing.
NL176076C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
NL175525C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
NL930014I2 (nl) 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
NL7806163A (nl) Farmaceutisch preparaat met anti-bacteriele werking.
NL7903973A (nl) 1,2,4-triazolidinonen-3 en thionen-3.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NL7904846A (nl) Cefalosporinederivaat, bereiding hiervan en toepassing hiervan in een antibacterieel preparaat.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee